J9328 Temozolomide injection
Also known as: temozolomide, Temodar
Injection of temozolomide, a methylating alkylating agent. Used for glioblastoma and melanoma.
In Plain Language
brain cancer injection; glioblastoma treatment
Clinical Context
Used for glioblastoma multiforme with radiation therapy. Also used for metastatic melanoma and other brain tumors.
RVU Information
CPT J9328 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9328?
CPT J9328 (Temozolomide injection) is a J Codes (Drugs) code. Injection of temozolomide, a methylating alkylating agent. Used for glioblastoma and melanoma.
How is J9328 administered?
CPT J9328 is administered by a healthcare provider, typically via injection or infusion. Used for glioblastoma multiforme with radiation therapy. Also used for metastatic melanoma and other brain tumors. It is used by Oncology, Neurosurgery, Dermatology.
When is CPT J9328 used?
Used for glioblastoma multiforme with radiation therapy. Also used for metastatic melanoma and other brain tumors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.